Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1499PDF: 848HTML: 964figures: 150table 1: 162table2: 159table3: 161 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4696PDF: 1704HTML: 2685Untitled: 188 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3720Suppl. Files: 1030PDF: 1017Html: 105 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3157PDF: 1188HTML: 8078 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
800PDF: 477HTML: 1282 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
925PDF: 511HTML: 711 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3619PDF: 1202HTML: 3862Untitled: 182Untitled: 240 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3654PDF: 1406HTML: 456Figures . Eliassian: 198 -
IMMUNOLOGY OF TUBERCULOSIS
5106PDF: 1954HTML: 7244Untitled: 185 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10273PDF: 6161HTML: 21737 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
886PDF: 555HTML: 2176Cover Letter: 169 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3199PDF: 1307HTML: 2604 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1847PDF: 1121HTML: 247 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1326PDF: 783HTML: 3100 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3974PDF: 1513HTML: 814 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1097PDF: 580HTML: 6780 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1310PDF: 1264HTML: 78 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3203PDF: 1267HTML: 6169 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2947PDF: 989HTML: 3056 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1236PDF: 976HTML: 105 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6710PDF: 3826HTML: 24839 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3132PDF: 968HTML: 1986







